Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Health Care Sector · Oak Associates

Live Oak Health Sciences Fund (LOGSX)

Ticker LOGSX · · Holdings as of Jul 31, 2026

Expense ratio
1.04%$104/yr per $10k
5-yr return
+8.1%annualized
1-yr return
+19.6%as of Dec 2025
Net assets
$56.1Mall share classes
Holdings
28

Bottom line

Is LOGSX a good fund? The bottom line

LOGSX is a managed health care sector mutual fund from Oak Associates.

Annual fees run 1.04% — about $104 a year on every $10,000 invested, more expensive than 56% of health care sector funds we track.

It returned +19.6% over one year, +8.1% a year over five years, +7.3% a year over ten (as of Dec 31, 2025, per its prospectus).

With $56.1 million in net assets and 28 holdings, its largest position is N/a (6.9%) and the top 10 make up 51.8% of the portfolio.

What stands out

  • 5-year return beat 95% of category peers

What to watch

  • Concentrated: top 10 holdings are 51.8% of assets

Updated Nov 19, 2026

What LOGSX invests in

The Fund seeks long-term capital growth.

The Fund invests primarily in common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. These health science companies include pharmaceutical firms, designers and manufacturers of medical equipment and supplies, operators of hospitals, other health-care services, and biotechnological researchers and developers. The Fund has adopted a policy to concentrate its investments (invest at least 25% of its assets) in companies doing business in the health science industry, but will regularly invest in health science companies well in excess of this amount. The Fund invests primarily in common stocks of U.S. companies, but may, to a lesser extent, invest in equity REITs, common stocks of foreign companies and American Depositary Receipts (ADRs) that meet the investment criteria of…

From the fund's prospectus (filed Feb 27, 2026).

LOGSX performance

Fund calendar-year total returns, 2016–2025 2016: −0.4%; 2017: +13.4%; 2018: −4.0%; 2019: +19.0%; 2020: +6.0%; 2021: +17.5%; 2022: +3.7%; 2023: +1.2%; 2024: +0.2%; 2025: +19.6% −0% 2016 +13% 2017 −4% 2018 +19% 2019 +6% 2020 +18% 2021 +4% 2022 +1% 2023 +0% 2024 +20% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
LOGSX+19.6%+8.1%+7.3%
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of Dec 31, 2025

Full LOGSX performance history →

What LOGSX costs

On a $10,000 investment, LOGSX's 1.04% expense ratio costs about $104 a year. The prospectus estimates $1,271 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full LOGSX fee table →

LOGSX top 10 holdings

#Holding% of fund
1N/a6.91%
2Cardinal Health Inc5.86%
3Jazz Pharmaceuticals Plc5.77%
4United Therapeutics Corp5.11%
5Exelixis Inc4.95%
6Amgen Inc4.86%
7Lantheus Holdings Inc4.68%
8Novartis Ag4.67%
9Mckesson Corp4.53%
10Cencora Inc4.46%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 51.8% of the fund. See all top 25 holdings and asset mix →

Alternatives to LOGSX

More funds like LOGSX →

LOGSX FAQ

What is the expense ratio of LOGSX?
LOGSX's expense ratio is 1.04%, which works out to about $104 a year for every $10,000 invested. The prospectus estimates total costs of $1,271 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is LOGSX a good investment?
It depends on your goals, but the data points to: 5-year return beat 95% of category peers; concentrated: top 10 holdings are 51.8% of assets. This is general information, not personalized advice.
What does LOGSX hold?
LOGSX's largest holdings are N/a (6.9%), Cardinal Health Inc (5.9%), Jazz Pharmaceuticals Plc (5.8%), United Therapeutics Corp (5.1%), Exelixis Inc (5.0%). It holds 28 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is LOGSX's 5-year return?
LOGSX returned +8.1% a year over the five years ending Dec 31, 2025, and +7.3% a year over ten years. Past performance does not guarantee future results.
Who manages LOGSX?
LOGSX is offered by Oak Associates through Oak Associates Funds.